The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


MEMANTINE



Ranbaxy Ireland LimitedPA0408/093/001

Main Information

Trade NameMEMANTINE
Active SubstancesMEMANTINE HYDROCHLORIDE
Dosage FormFilm Coated Tablet
Licence HolderRanbaxy Ireland Limited
Licence NumberPA0408/093/001

Group Information

ATC CodeN06DX01 memantine

Status

License statusWithdrawn
Withdrawn Date30/06/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back